Epidemiology of Breast Cancer Epidemiology and prognosis of breast cancer in young women Lack of patient-reported outcomes assessment in phase III breast cancer studies： a missed opportunity for informed decision making Advances in Basic Research of Breast Cancer Breast cancer in the young： role of the geneticist An update on the genomic landscape of breast cancer： new opportunity for personalized therapy? Towards the elucidation of the mechanisms underlying breast cancer mutations Members of the BRCA1 complexes as new susceptibility genes for breast cancer APOBEC3B spreads somatic mutations in breast cancer genome From genomic data analysis to drug development： a new generation of trials using molecular marker assessment in breast cancer MET deregulation in breast cancer Circulating free DNA in the management of breast cancer Imaging Examination of Breast Cancer Breast imaging in the young： the role of magnetic resonance imaging in breast cancer screening，diagnosis and follow-up Treatment of Breast Cancer Challenges in managing breast cancer during pregnancy Premature menopause in young breast cancer： effects on quality of life and treatment interventions Surgical Treatment Conservative mastectomies for breast cancer and risk-reducing surgery： the Memorial Sloan Kettering Cancer Center experience Oncoplastic techniques in breast surgery for special therapeutic problems Oncological safety of prophylactic breast surgery： skin-sparing and nipple-sparing versus total mastectomy Anatomy relevant to conservative mastectomy Breast reconstruction following conservative mastectomies： predictors of complications and outcomes Surgical management of breast cancer in China： the Fudan University Shanghai Cancer Center experience Endocrine Therapy Paradigm of polyendocrine therapy in endocrine responsive breast cancer： the role of fulvestrant Bisphosphonates in the adjuvant treatment of young women with breast cancer： the estrogen rich is a poor candidate！ Hormonal therapies in young breast cancer patients： when， what and for how long? A balancing act for breast cancer? Everolimus for hormone receptor positive patients Chemotherapy Treatment of breast cancer in young women： do we need more aggressive therapies? Neoadjuvant bevacizumab and chemotherapy in breast cancer Radiotherapy Impact of preoperative magnetic resonance imaging in breast cancer patients candidates for an intraoperative partial breast irradiation First year experience with IORT for breast cancer at the Geneva University Hospitals CyberKnife stereotaetie body radiotherapy and CyberKnife aeeelerated partial breast irradiation for the treatment of early breast cancer Brest experience in intraoperative radiotherapy for breast cancer Intraoperative radiotherapy with electrons （ELIOT） for early breast cancer： the European Institute of Oneology experience Comparison of the proliferative and elonogenie growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapy The use of postoperative radiation after nipple sparing mastectomy Optimal management of sentinel lymph node positive biopsy patients in early breast cancer Targeted Therapy Should trastuzumab be administered concomitantly with anthracycline in women with early， HER2-positive breast cancer? Pertuzumab in metastatic breast cancer： unanswered questions Pertuzumab： a step forward in treating HER2-positive breast cancer Bevacizumab： Where do we go from here in breast cancer? Lapatinib as a therapeutic option in brain metastases from HER2+ breast cancer The ALTERNATE trial： assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancer Nanoparticle Therapy Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer Prognosis of Breast Cancer Fertility counseling of young breast cancer patients Sexuality and breast cancer： prime time for young patients Breast cancer and sleep disturbance： more than simply a quality of life concern Brain metastases in HER2 positive breast cancer： the next hurdle Brain metastases in HER2-positive breast cancer： challenges and opportunities
鄂公網(wǎng)安備 42010302001612號 